Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RUNGANYANGXIN decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is specifically designed for the treatment of cardiac neurosis, particularly the subtype characterized by heart and liver Yin deficiency. The decoction aims to nourish Yin, soothe the liver, and calm the heart to alleviate clinical symptoms such as palpitations, chest tightness, and anxiety. Clinical research, including randomized double-blind controlled trials, has explored its efficacy and biological mechanism by evaluating its impact on the autonomic nervous system through heart rate variability (HRV) parameters. It is typically administered as an oral solution prepared from a specific combination of botanical extracts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on runganyangxin decoction.